Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Yescarta (axicabtagene ciloleucel) for the Treatment of Large B-Cell Lymphoma

Drug (Brand / Generic)

Yescarta (axicabtagene ciloleucel)

Therapy Class

Chimeric antigen receptor (CAR)-positive T cell therapy

Current Indication

B-cell lymphoma

Market Sector

Oncology

Development Status

Approved in the US
Expand

Go Top